HomeBusinessHealthcare Industry Stock NewsEmbecta (EMBC) CEO On Diabetes Care & Company Earnings

Embecta (EMBC) CEO On Diabetes Care & Company Earnings

Embecta (EMBC) is a diabetes care company. Its products include a range of pen needles, syringes, and safety injection devices. EMBC distributes products through a variety of channels including retail, hospitals, pharmacies, and other institutional channels. CEO Dev Kurdikar joins Oliver Renick to give an overview of EMBC. He discusses EMBC's earnings. Its 3Q adjusted EPS came in at $0.69 versus an estimated $0.44 and revenue came in at $286.10M versus an estimated $281.81M. EMBCA revenues are down 0.3% on a constant currency basis and down 1.7% on a reported basis. He talks about EMBC's new product pipeline. Tune in to find out more about the stock market today.

Market On Close

09 Aug 2023

SHARE

ON AIR
4:30 pm
Market Overtime
replay
12:00 am
Fast Market
REPLAY
education
1:00 am
Your First Trade
REPLAY
1:30 am
Next Gen Investing
REPLAY
education
2:30 am
Your First Trade
REPLAY
3:00 am
Trading 360
REPLAY
4:00 am
Fast Market
REPLAY
5:00 am
Next Gen Investing
REPLAY
education
6:00 am
Your First Trade
REPLAY
6:30 am
Trading 360
REPLAY
7:30 am
Fast Market
REPLAY
8:30 am
Next Gen Investing
REPLAY
9:30 am
Market Overtime
REPLAY
10:00 am
Trading 360
REPLAY
11:00 am
Fast Market
REPLAY
12:00 pm
Next Gen Investing
REPLAY
education
1:00 pm
Your First Trade
REPLAY
1:30 pm
Trading 360
REPLAY
2:30 pm
Fast Market
REPLAY
3:30 pm
Next Gen Investing
REPLAY
ON AIR
4:30 pm
Market Overtime
REPLAY
5:00 pm
Trading 360
REPLAY
6:00 pm
Fast Market
REPLAY
7:00 pm
Next Gen Investing
REPLAY
8:00 pm
Market Overtime
REPLAY
8:30 pm
Trading 360
REPLAY
9:30 pm
Fast Market
REPLAY
10:30 pm
Next Gen Investing
REPLAY
education
11:30 pm
Your First Trade
REPLAY

Get the Market Minute

Daily insights for every investor

coming soon

We are now

coming soon

We are now